Ibuprofeno comparado con acetazolamida para prevención de mal agudo de montaña / Ibuprofen versus acetazolamide for prevention of acute mountain sickness

INTRODUCCIÓN: El mal agudo de montaña es una condición frecuente en individuos sanos, sin aclimatación que se exponen a alturas desde 2500 metros sobre el nivel del mar. Clásicamente se ha utilizado acetazolamida para prevenirlo, pero en los últimos años ha surgido evidencia a favor de ibuprofeno. Sin embargo, no está claro cuál de estos tratamientos es más efectivo. MÉTODOS: Realizamos una búsqueda en Epistemonikos, la mayor base de datos de revisiones sistemáticas en salud, la cual es mantenida mediante el cribado de múltiples fuentes de información, incluyendo MEDLINE, EMBASE, Cochrane, entre otras. Extrajimos los datos desde las revisiones identificadas, analizamos los datos de los estudios primarios, realizamos un metanálisis y preparamos una tabla de resumen de los resultados utilizando el método GRADE. RESULTADOS Y CONCLUSIONES: Identificamos dos revisiones sistemáticas que en conjunto incluyeron un estudio primario, el cual corresponde a un ensayo aleatorizado. Concluimos que no es posible establecer con claridad si ibuprofeno es mejor o peor que acetazolamida debido a que la certeza de evidencia existente ha sido evaluada como muy baja.

INTRODUCTION: Acute mountain sickness is a common condition occurring in healthy subjects that undergo rapid ascent without prior acclimatization, as low as 2500 meters above sea level. The classic preventive agent has been acetazolamide, although in the last decade there has been evidence favoring ibuprofen. However, it is unclear which method is more efficient. METHODS: We searched in Epistemonikos, the largest database of systematic reviews in health, which is maintained by screening multiple information sources, including MEDLINE, EMBASE, Cochrane, among others. We extracted data from the systematic reviews, reanalyzed data of primary studies, conducted a meta-analysis) and generated a summary of findings table using the GRADE approach. RESULTS AND CONCLUSIONS: We identified two systematic reviews that included only one primary study, which is a randomized trial. We concluded it is not possible to establish whether ibuprofen is better or worse than acetazolamide because the certainty of evidence has been evaluated as very low.

Biomarcadores de lesión miocárdica y edema pulmonar de las alturas / Biological markers of myocardial damage and high-altitude pulmonary edema

El edema pulmonar de las alturas es una entidad potencialmente fatal que se presenta en individuos que ascienden rápidamente por encima de 2.500 msnm. La hipoxia, el deterioro de la clase funcional y la dificultad respiratoria son el resultado de un edema pulmonar no cardiogénico. En este caso clínico de edema pulmonar de las alturas se encontró elevación de biomarcadores de lesión miocárdica y de sobrecarga de presión, sin compromiso estructural cardiaco o coronario, hallazgo que no ha sido ampliamente documentado. En observaciones recientes se ha evidenciado la elevación del péptido natriurético cerebral (BNP por su sigla en Inglés) en pacientes con enfermedad de las alturas y edema pulmonar de las alturas, con solo un caso clínico publicado que reportó elevación de la troponina asociado a edema pulmonar de las alturas.

The high-altitude pulmonary edema is a potentially fatal condition that occurs in people who rapidly ascend above 2,500 m. Hypoxia, functional class deterioration, and breathing difficulty are due to a non-carcinogenic pulmonary edema. In this case report of high-altitude pulmonary edema, we found an elevation of biomarkers of myocardial damage without myocardial or coronary compromise. This finding has not been widely documented. Recent observations have shown the elevation of brain natriuretic peptide, and even a case with positive troponin associated with high-altitude pulmonary edema has been found.

Advice for Individuals Travelling to High Altitude

More people are traveling to remote places for leisure and business. It is not uncommon for patients to get medication and advice for travel to high altitudes. Although high altitude cerebral and pulmonary oedemas are more frequent at very high and extreme altitudes, they may sometimes occur at lower altitudes and lead to fatalities. Even though acute mountain sickness (AMS) is generally deemed benign, it can easily wreck a holiday. The Lake Louise Score Questionnaire is a useful screening tool for AMS and it can be self-administered during travel. Non-pharmacological means in the prevention and treatment of AMS, especially acclimatisation, are the most important. Pharmacological prevention and treatment strategies should be used as a useful adjunct. This paper provides an approach to the provision of education and advice for high altitude travel in the primary care setting.

Bilateral lateral rectus palsies in high altitude illness.

A 50-year-old man with high altitude illness had bilateral lateral rectus palsies when he went to the Himalaya at 5,000 meters. He had no other neurological signs, except headache. He received acetazolamide, prednisone, and spent time in a hyperbaric chamber; but unfortunately he showed no improvement. Two months later, his diplopia completely resolved itself without any treatment, after his descent to a lower altitude.

Screening of new human carbonic anhydrase Ⅱ(hCA Ⅱ) inhibitors / 中国药理学通报

Aim To provide practical method for screening human carbonic anhydrase Ⅱ(hCA Ⅱ) inhibitors in drug discovery.Methods hCA Ⅱ protein was obtained from induced BL21(DE3) E.coli containing plasmid pET-28b-hCA Ⅱ.The hCA Ⅱ activity was detected under pH 7.6 and 25℃ by its esterase activity which could decompose PNPA to increase the photoabsorption at 348 nm. After the assay conditions were finally selected, 35 new compounds were tested.Results A practical method for screening hCA Ⅱ inhibitors was successfully constituted by using recombinant hCA Ⅱ protein expressed in E.coli as the source of hCA Ⅱ enzyme.10 new compounds had better inhibitory effect and 9 new compounds had the same inhibitory effect on hCA Ⅱ compared with acetazolamide.Conclusions The hCA II inhibitor screening technique constituted in this work possesses advantages of being reliable, rapid, and practical. 19 new compounds are worth further research for developing high efficiency and low side effect drugs used for high-altitude illness.

Treatment and Prevention of High Altitude Illness and Mountain Sickness

High-altitude illness is used to describe various symptoms that can develop in unacclimatized persons on ascent to high altitude. Symptoms usually include headache, anorexia, nausea, vomiting, fatigue, dizziness, and sleep disturbance. In fact, high-altitude illness comprises of acute mountain sickness (AMS) and its life-threatening complications, high-altitude cerebral edema (HACE) and high-altitude pulmonary edema (HAPE). Since there are many travelers who visit high-altitude locations these days, high-altitude illness has become a public health problem. Therefore, physicians need to be familiar with the condition and be able to advise those who are going to reach high altitude how to prevent or minimize the illness and treat patients who suffer from it.